曲美他嗪与阿托伐他汀联合治疗冠心病的临床效果分析

李家军

（旬阳县中医院，陕西 安康，725700）

浏览次数：64次 下载次数：306次

摘要：

目的 分析曲美他嗪与阿托伐他汀联合治疗冠心病的临床效果。方法 回顾性分析我院收治的120例冠心病患者的临床资料，根据不同治疗方式将其分为A 组（40 例，给予曲美他嗪治疗）、B组（40例，给予阿托伐他汀治疗）以及C组（40例， 给予曲美他嗪与阿托伐他汀联合治疗）。对比三组患者的血脂改善及临床症状缓解情况。结果 治疗后，A组与B 组患者的各血脂指标水平稍优于治疗前，但差异无统计学意义（P>0.05）；C组患者治疗后的LDL-C、TG及TC水平降低，HDL-C水平升高，且均优于治疗后的A组与B组（P<0.05）。A、B组患者的心悸、胸部疼痛以及全身乏力缓解率比较，无显著差异（P>0.05）； 与A、B组相比较，C组患者的心悸、胸部疼痛以及全身乏力缓解率更高（P<0.05）。结论 曲美他嗪与阿托伐他汀联合治疗冠心病患者的临床效果十分显著，有利于进一步改善患者的血脂指标水平与临床症状，值得在临床治疗工作中推广运用。

关键词：曲美他嗪；阿托伐他汀；冠心病

中图分类号：R541.4文献标志码：A文章编号：2096-1413(2017)31-0040-02

Clinical analysis of trimetazidine combined with atorvastatin in the treatment of coronary heart disease
LI Jia-jun
(Xunyang County Hospital of Traditional Chinese Medicine, Ankang 725700, China)

ABSTRACT: Objective To analyze the clinical effect of trimetazidine combined with atorvastatin in the treatment of coronary heart disease. Methods The clinical data of 120 patients with coronary heart disease who treated in our hospital were retrospectively analyzed. The patients were divided into the group A (40 cases, received trimetazidine treatment), the group B (40 cases, received atorvastatin treatment) and the group C (40 cases, received trimetazidine combined with atorvastatin treatment) according to different treatment methods. The blood lipids improvement and clinical symptoms situation were compared among the three groups. Results After treatment, the levels of blood lipids in the group A and B were slightly better than those before treatment, but the differences were not statistically significant (P>0.05); the levels of LDL-C, TG and TC decreased and the level of HDL-C increased in the group C, and those were better than the group A and group B (P<0.05). There were no significant differences in the palpitations, chest pain and generalized fatigue remission rate between the group A and group B (P>0.05); compared with the group A and group B, the palpitations, chest pain and generalized fatigue remission rate were higher in the group C (P<0.05). Conclusion Timetazidine combined with atorvastatin has remarkable effect on coronary heart disease, which is helpful to further improve the blood lipids indexes levels and clinical symptoms, and it is worth to be used in clinical treatment.
KEYWORDS: trimetazidine; atorvastatin; coronary heart disease

参考文献：
[1] 曾有儒.阿托伐他汀联合曲美他嗪治疗冠心病的临床疗效分析[J]. 吉林医学,2014,35(1):96-97.
[2] 陈高举.曲美他嗪及阿托伐他汀联合治疗冠心病患者的临床效果 观察[J].当代医学,2015,21(14):109-110.
[3] 李小晶.阿托伐他汀联合曲美他嗪治疗冠心病的临床效果观察[J]. 中国当代医药,2015,22(18):97-99.
[4] 姜莹.曲美他嗪与阿托伐他汀联合治疗冠心病的临床效果观察[J]. 中国实用医药,2015,10(26):141-142.
[5] 杨琴.80 例冠心病患者采用阿托伐他汀联合曲美他嗪治疗的临床 对比研究[J].海峡药学,2015,27(9):148-149.
[6] 崔自慧.冠心病患者应用阿托伐他汀联合曲美他嗪治疗的临床疗 效分析[J].中国现代药物应用,2016,10(2):173-174.
[7] 李东宝,沈潞华.羟甲基戊二酰辅酶A 还原酶抑制剂对细胞增殖 和凋亡的影响[J].中国新药与临床杂志,2000,19(5):347-349.
[8] 李曾玉,罗经维.曲美他嗪对冠心病心绞痛合并糖尿病患者治疗的 影响[J].基层医学论坛,2015,19(20):2739-2740.